VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
+8.79%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
AUM
$31.9M
AUM Growth
Cap. Flow
+$31.9M
Cap. Flow %
100%
Top 10 Hldgs %
36.35%
Holding
73
New
72
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 52.15%
2 Energy 30.72%
3 Utilities 5.21%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CEQP
26
DELISTED
Crestwood Equity Partners LP
CEQP
$407K 1.12%
+19,580
New +$407K
ADXS
27
DELISTED
Advaxis, Inc.
ADXS
$334K 0.92%
+2,216
New +$334K
ATRA icon
28
Atara Biotherapeutics
ATRA
$89.9M
$321K 0.88%
+485
New +$321K
BLCM
29
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$306K 0.84%
+1,509
New +$306K
RXDX
30
DELISTED
Ignyta, Inc.
RXDX
$303K 0.83%
+22,638
New +$303K
PRTK
31
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$300K 0.82%
+15,819
New +$300K
ISEE
32
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$293K 0.8%
+3,735
New +$293K
ARWR icon
33
Arrowhead Research
ARWR
$3.87B
$292K 0.8%
+47,549
New +$292K
TVRD
34
Tvardi Therapeutics, Inc. Common Stock
TVRD
$285M
$292K 0.8%
+481
New +$292K
GERN icon
35
Geron
GERN
$880M
$288K 0.79%
+59,436
New +$288K
PTLA
36
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$286K 0.79%
+5,561
New +$286K
INSM icon
37
Insmed
INSM
$30.1B
$285K 0.78%
+15,716
New +$285K
SRE icon
38
Sempra
SRE
$53.6B
$284K 0.78%
+6,034
New +$284K
IMMU
39
DELISTED
Immunomedics Inc
IMMU
$284K 0.78%
+92,480
New +$284K
SGMO icon
40
Sangamo Therapeutics
SGMO
$160M
$282K 0.77%
+30,847
New +$282K
CLVS
41
DELISTED
Clovis Oncology, Inc.
CLVS
$280K 0.77%
+7,999
New +$280K
ACAD icon
42
Acadia Pharmaceuticals
ACAD
$4.3B
$279K 0.77%
+7,814
New +$279K
SRPT icon
43
Sarepta Therapeutics
SRPT
$1.93B
$278K 0.76%
+7,203
New +$278K
RLYP
44
DELISTED
RELYPSA INC COM
RLYP
$278K 0.76%
+9,802
New +$278K
LJPC
45
DELISTED
La Jolla Pharmaceutical Company
LJPC
$277K 0.76%
+10,250
New +$277K
MGNX icon
46
MacroGenics
MGNX
$123M
$276K 0.76%
+8,911
New +$276K
CASC
47
DELISTED
Cascadian Therapeutics, Inc.
CASC
$275K 0.75%
+20,654
New +$275K
NVAX icon
48
Novavax
NVAX
$1.27B
$274K 0.75%
+1,636
New +$274K
LXRX icon
49
Lexicon Pharmaceuticals
LXRX
$389M
$273K 0.75%
+20,486
New +$273K
TSRO
50
DELISTED
TESARO, Inc.
TSRO
$273K 0.75%
+5,210
New +$273K